Comentario al artículo Intracavitary Application of Novantran in Breast Cancer CNS Metastasis. Case Report
Vicente Calatayud
Zaragoza
Read
1441
Timeswas read the article
754
Total PDF
687
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 March | 1 | 4 | 5 |
| 2022 November | 1 | 0 | 1 |
| 2018 February | 10 | 3 | 13 |
| 2018 January | 14 | 7 | 21 |
| 2017 December | 14 | 6 | 20 |
| 2017 November | 44 | 13 | 57 |
| 2017 October | 5 | 6 | 11 |
| 2017 September | 9 | 6 | 15 |
| 2017 August | 8 | 9 | 17 |
| 2017 July | 8 | 7 | 15 |
| 2017 June | 13 | 12 | 25 |
| 2017 May | 16 | 8 | 24 |
| 2017 April | 11 | 7 | 18 |
| 2017 March | 10 | 14 | 24 |
| 2017 February | 6 | 10 | 16 |
| 2017 January | 7 | 9 | 16 |
| 2016 December | 18 | 18 | 36 |
| 2016 November | 18 | 16 | 34 |
| 2016 October | 13 | 23 | 36 |
| 2016 September | 25 | 19 | 44 |
| 2016 August | 36 | 16 | 52 |
| 2016 July | 32 | 23 | 55 |
| 2015 December | 2 | 0 | 2 |
| 2015 July | 2 | 0 | 2 |
| 2015 June | 7 | 13 | 20 |
| 2015 May | 14 | 9 | 23 |
| 2015 April | 9 | 27 | 36 |
| 2015 March | 13 | 13 | 26 |
| 2015 February | 6 | 17 | 23 |
| 2015 January | 13 | 20 | 33 |
| 2014 December | 11 | 13 | 24 |
| 2014 November | 7 | 12 | 19 |
| 2014 October | 20 | 20 | 40 |
| 2014 September | 12 | 23 | 35 |
| 2014 August | 17 | 24 | 41 |
| 2014 July | 12 | 15 | 27 |
| 2014 June | 18 | 17 | 35 |
| 2014 May | 18 | 13 | 31 |
| 2014 April | 11 | 28 | 39 |
| 2014 March | 16 | 19 | 35 |
| 2014 February | 12 | 15 | 27 |
| 2014 January | 13 | 24 | 37 |
| 2013 December | 10 | 21 | 31 |
| 2013 November | 12 | 8 | 20 |
| 2013 October | 11 | 9 | 20 |
| 2013 September | 13 | 11 | 24 |
| 2013 August | 17 | 13 | 30 |
| 2013 July | 11 | 8 | 19 |
| 2013 June | 4 | 13 | 17 |
| 2013 May | 10 | 19 | 29 |
| 2013 April | 6 | 31 | 37 |
| 2013 March | 9 | 12 | 21 |
| 2013 February | 5 | 4 | 9 |
| 2013 January | 10 | 7 | 17 |
| 2012 December | 8 | 21 | 29 |
| 2012 November | 0 | 16 | 16 |
| 2012 October | 0 | 1 | 1 |
| 2012 September | 0 | 2 | 2 |
| 2012 January | 9 | 0 | 9 |
Show all
